Powered by IABC
Catalyst
  • Innovation
  • Business Acumen
  • Career Roadmap
  • Gold Quill
  • Podcasts
  • About
Creating a Scientific Reputation for Astellas: The Astellas Corporate Scientific Innovation Narrative
Gold Quill | 22 June 2020
Creating a Scientific Reputation for Astellas: The Astellas Corporate Scientific Innovation Narrative
by: Stefanie Prodouz

The Astellas Scientific Innovation Narrative toolkit, a first of its kind initiative, was developed to help Astellas leaders deliver powerful and compelling strategic communications, internally and externally. The Narrative brought together a complex matrix of different innovation functions under one messaging platform, across geographies and languages, to describe scientific innovation at Astellas. The objective of the Narrative was to differentiate and communicate the company’s unique approach to innovation and pipeline in an extremely competitive external innovation environment and, persuasively and consistently, convey Astellas’ scientific story to key internal and external stakeholders — ultimately, to build Astellas’ corporate scientific reputation and enhance its perception as a ‘company of choice’ among potential innovation partners and current/prospective employees.

The business need

Astellas is a top 25 global pharmaceutical company with a research and development (R&D) approach centered on the delivery of breakthrough innovations for maximum patient benefit. With the pharmaceutical industry in a state of rapid change, companies such as Astellas are navigating an environment that is continually evolving and being shaped by a multitude of factors. One key area is scientific innovation. The way pharma companies discover, research and develop innovation is undergoing a revolution – the old model of in-house development teams is becoming a thing of the past. Now pharma is looking outwards, for high-quality partnerships with academia and biotechnology companies, creating a new competitive frontier in the industry; a frontier which will decide the winners of the future.

In addition, pharma is dealing with multiple pressures such as increased competition, access and policy regulations, the needs of different geographical markets, and intense pricing pressure from payors. These factors, combined with unprecedented competition for hiring and retaining talent means, more than ever before, the companies that will emerge victorious will need a powerful, compelling, consistent story, communicated internally and externally, across all touchpoints.

Working within this challenging environment, it is vital that leaders of pharmaceutical companies can effectively communicate their scientific innovation positioning and pipeline in order to connect with key stakeholders, forge meaningful partnerships and clearly differentiate from competitors. However, prior to this initiative, Astellas’ leaders were not equipped with consistent, strategically aligned and engaging messaging to enable them to articulate, with one single voice and global story, the company’s approach to scientific innovation and pipeline. As a result, before the Astellas Scientific Innovation Narrative, there was poor internal and external understanding of, and support for, the company’s innovation approach, R&D strategy and pipeline, with key stakeholders reporting that Astellas’ R&D strategy and pipeline seemed disparate and non-strategic.

Read the case study here.


Stefanie Prodouz
Business Acumen
Communication Can Calm Chaos: World Conference 2022 Preview
23 June 2022
Communication Can Calm Chaos: World Conference 2022 Preview
by: Jenni Field

Communication can calm chaos because it is the golden thread that runs through organizations.

Innovation
Before, During and After: Managing Cybersecurity Communications
22 June 2022
Before, During and After: Managing Cybersecurity Communications
by: Paige Strand

Everyone plays a role in ensuring the organization is protected from cybersecurity incidents — especially communicators — from proactive planning to reactive measures in the moment. What should we focus on first?

Business Acumen
ESG — Communicating the Greater Good
22 June 2022
ESG — Communicating the Greater Good
by: Joe Bobbey, Stephen Forshaw and Tammy Korgie

Having a solid understanding of ESG and related trends is the first step to being a more effective ESG communicator.

Contact Us
330 N Wabash Avenue, Suite 2000, Chicago, IL 60611 USA
Phone: 312.321.6868 | Toll-Free: 800.218.8097 | E-mail: member_relations@iabc.com
Login
Search